Kineret 100 mg/.67mL
anakinra · INJECTION, SOLUTION · Swedish Orphan Biovitrum AB (publ)
No Recall History
Plain English
Kineret is a injection, solution containing anakinra at 100 mg/.67mL, taken subcutaneous. Manufactured by Swedish Orphan Biovitrum AB (publ).
Key Facts
- Brand Name
- Kineret
- Generic Name
- anakinra
- NDC Code (Product)
66658-234- Manufacturer
- Swedish Orphan Biovitrum AB (publ)
- Strength
- 100 mg/.67mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103950
- Drug Class
- Interleukin-1 Receptor Antagonist [EPC]
- Marketing Start
- 12/15/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is Kineret used for?
Kineret contains anakinra. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Kineret a controlled substance?
Kineret is not classified as a controlled substance by the DEA.
What is the generic name for Kineret?
The generic name for Kineret is anakinra. There are no other listed brand versions of anakinra.
What is the NDC code for Kineret 100 mg/.67mL?
The NDC (National Drug Code) for Kineret 100 mg/.67mL is 66658-234, listed by Swedish Orphan Biovitrum AB (publ).
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)